首页> 美国卫生研究院文献>International Journal for Parasitology: Drugs and Drug Resistance >TPT sulfonate a single oral dose schistosomicidal prodrug: In vivo efficacy disposition and metabolic profiling
【2h】

TPT sulfonate a single oral dose schistosomicidal prodrug: In vivo efficacy disposition and metabolic profiling

机译:TPT磺酸盐一种单剂量口服血吸虫病前药:体内功效处置和代谢状况分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Treatment of schistosomiasis relies precariously on just one drug, praziquantel (PZQ). In the search for alternatives, 15 S-[2-(alkylamino)alkane] thiosulfuric acids were obtained from a previous research program and profiled in mice for efficacy against both mature (>42-day-old) and juvenile (21-day-old) Schistosoma mansoni using a screening dose of 100 mg/kg PO QDx4. One compound, S-[2-(tert-butylamino)-1-phenylethane] thiosulfuric acid (TPT sulfonate), was the most effective by decreasing female and male worm burdens by ≥ 90% and ≥46% (mature), and ≥89% and ≥79% (juvenile), respectively. In contrast, PZQ decreased mature female and male worm burdens by 95% and 94%, respectively, but was ineffective against juvenile stages. Against 7-day-old lung-stage worms, TPT sulfonate was only effective at twice the dose decreasing female and male burdens by 95 and 80%, respectively. Single oral doses at 400 and/or 600 mg/kg across various developmental time-points (1-, 7-, 15-, 21- and/or 42 day-old) were consistent with the QD x4 data; efficacy was strongest once the parasites had completed lung migration, and female and male burdens were decreased by at least 90% and 80%, respectively. In vitro, TPT sulfonate is inactive against the parasite suggesting a pro-drug mechanism of action. In mice, TPT sulfonate is fully absorbed and subject to rapid, non-CYP-mediated, first-pass metabolism that is initiated by desulfation and yields a series of metabolites. The initially-formed free thiol-containing metabolite, termed TP thiol, was chemically synthesized; it dose-dependently decreased S. mansoni and Schistosoma haematobium motility in vitro. Also, when administered as a single 50 mg/kg IP dose, TP thiol decreased 33-day-old S. mansoni female and male burdens by 35% and 44%, with less severe organomegaly. Overall, TPT sulfonate's efficacy profile is competitive with that of PZQ. Also, the characterization of a parasiticidal metabolite facilitates an understanding and improvement of the chemistry, and identification of the mechanism of action and/or target.
机译:血吸虫病的治疗不稳定地仅依赖一种药物吡喹酮(PZQ)。在寻找替代品的过程中,从以前的研究计划中获得了15 S- [2-(烷基氨基)烷烃]硫代硫酸,并在小鼠中分析了其对成熟(> 42天大)和少年(21天-大)的功效。老年)曼氏血吸虫,筛查剂量为100μmg/ kg PO QDx4。一种化合物S- [2-(叔丁基氨基)-1-苯基乙烷]硫代硫酸(TPT磺酸盐)是最有效的化合物,它可以将雌虫和雄虫的负担减少90%或90%以上和46%(成熟),并且≥分别为89%和≥79%(青少年)。相比之下,PZQ分别将成熟的雌性和雄性蠕虫负担减少了95%和94%,但对幼虫期无效。对于7天大的肺部蠕虫,TPT磺酸盐仅以两倍的剂量有效,分别使雌性和雄性负担减少95%和80%。在各个发育时间点(1、7、15、21和/或42天龄)以400和/或600μmg/ kg的单次口服剂量与QD x4数据一致;一旦寄生虫完成了肺部迁移,其功效最强,雌性和雄性负担分别减少了至少90%和80%。在体外,TPT磺酸盐对寄生虫无活性,提示其前药作用机制。在小鼠中,TPT磺酸盐被完全吸收,并经历快速的,非CYP介导的首过代谢,该代谢由脱硫引发并产生一系列代谢产物。化学合成了最初形成的游离的含硫醇的代谢物,称为TP硫醇。它在体外剂量依赖性地降低曼氏沙门氏菌和血吸虫血红蛋白运动性。同样,当以单剂量50μmg/ kg IP剂量给药时,TP硫醇可将33天大的曼氏葡萄球菌的雌性和雄性负担减少35%和44%,严重的器官肿大也减轻了。总体而言,TPT磺酸盐的功效与PZQ竞争。同样,杀虫代谢产物的表征有助于对化学的理解和改进,以及作用机理和/或靶标的鉴定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号